341 related articles for article (PubMed ID: 36018527)
1. Cutting edge rare earth radiometals: prospects for cancer theranostics.
Sadler AWE; Hogan L; Fraser B; Rendina LM
EJNMMI Radiopharm Chem; 2022 Aug; 7(1):21. PubMed ID: 36018527
[TBL] [Abstract][Full Text] [Related]
2. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
3. Radiometals for imaging and theranostics, current production, and future perspectives.
Mikolajczak R; van der Meulen NP; Lapi SE
J Labelled Comp Radiopharm; 2019 Aug; 62(10):615-634. PubMed ID: 31137083
[TBL] [Abstract][Full Text] [Related]
4. Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy.
Nelson BJB; Andersson JD; Wuest F
Nucl Med Biol; 2022; 110-111():59-66. PubMed ID: 35487834
[TBL] [Abstract][Full Text] [Related]
5. Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside.
Van Laere C; Koole M; Deroose CM; de Voorde MV; Baete K; Cocolios TE; Duchemin C; Ooms M; Cleeren F
Theranostics; 2024; 14(4):1720-1743. PubMed ID: 38389843
[TBL] [Abstract][Full Text] [Related]
6.
Dellepiane G; Casolaro P; Mateu I; Scampoli P; Voeten N; Braccini S
Appl Radiat Isot; 2022 Nov; 189():110428. PubMed ID: 36049443
[TBL] [Abstract][Full Text] [Related]
7. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer.
Herrero Álvarez N; Bauer D; Hernández-Gil J; Lewis JS
ChemMedChem; 2021 Oct; 16(19):2909-2941. PubMed ID: 33792195
[TBL] [Abstract][Full Text] [Related]
9. A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with
Talip Z; Favaretto C; Geistlich S; Meulen NPV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093425
[TBL] [Abstract][Full Text] [Related]
10. Cross section measurement of terbium radioisotopes for an optimized
Dellepiane G; Casolaro P; Favaretto C; Grundler PV; Mateu I; Scampoli P; Talip Z; van der Meulen NP; Braccini S
Appl Radiat Isot; 2022 Jun; 184():110175. PubMed ID: 35344829
[No Abstract] [Full Text] [Related]
11. Interdisciplinary Tasks in the Cyclotron Production of Radiometals for Medical Applications. The Case of
Boschi A; Martini P; Costa V; Pagnoni A; Uccelli L
Molecules; 2019 Jan; 24(3):. PubMed ID: 30691170
[TBL] [Abstract][Full Text] [Related]
12. Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide
Loveless CS; Radford LL; Ferran SJ; Queern SL; Shepherd MR; Lapi SE
EJNMMI Res; 2019 May; 9(1):42. PubMed ID: 31098710
[TBL] [Abstract][Full Text] [Related]
13. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
[TBL] [Abstract][Full Text] [Related]
14. Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.
Notni J; Wester HJ
J Labelled Comp Radiopharm; 2018 Mar; 61(3):141-153. PubMed ID: 29143368
[TBL] [Abstract][Full Text] [Related]
15. Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging.
Favaretto C; Talip Z; Borgna F; Grundler PV; Dellepiane G; Sommerhalder A; Zhang H; Schibli R; Braccini S; Müller C; van der Meulen NP
EJNMMI Radiopharm Chem; 2021 Nov; 6(1):37. PubMed ID: 34778932
[TBL] [Abstract][Full Text] [Related]
16. Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production.
Tan HY; Wong YH; Kasbollah A; Md Shah MN; Perkins AC; Yeong CH
Nucl Med Commun; 2023 Apr; 44(4):227-243. PubMed ID: 36808108
[TBL] [Abstract][Full Text] [Related]
17. 3p-C-NETA: A versatile and effective chelator for development of Al
Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
[No Abstract] [Full Text] [Related]
18. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy.
Kostelnik TI; Orvig C
Chem Rev; 2019 Jan; 119(2):902-956. PubMed ID: 30379537
[TBL] [Abstract][Full Text] [Related]
19. Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes.
Hu A; Aluicio-Sarduy E; Brown V; MacMillan SN; Becker KV; Barnhart TE; Radchenko V; Ramogida CF; Engle JW; Wilson JJ
J Am Chem Soc; 2021 Jul; 143(27):10429-10440. PubMed ID: 34190542
[TBL] [Abstract][Full Text] [Related]
20. Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Meier JP; Zhang HJ; Freifelder R; Bhuiyan M; Selman P; Mendez M; Kankanamalage PHA; Brossard T; Pusateri A; Tsai HM; Leoni L; Penano S; Ghosh K; Broder BA; Markiewicz E; Renne A; Stadler W; Weichselbaum R; Nolen J; Kao CM; Chitneni SK; Rotsch DA; Szmulewitz RZ; Chen CT
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]